WeVote
Log In

Bill

Bill

SB 398

Relating to the delegation to a pharmacy technician of a pharmacist's authority to administer an immunization or vaccine.

89th Legislature (2025) Introduced by Kevin Sparks

SB 398 permits Texas pharmacists to delegate vaccine administration to pharmacy technicians, potentially accelerating vaccination access but raising patient safety and oversight concerns.

Referred to Health & Human Services
#immunizations(s4341) #occupationalregulation--healthoccupations(i0540) #pharmacies&pharmacists(s1192) #pharmacy #texasstateboardof(v0022)
0
WeVote Research Nonpartisan
Bill Summary · SB 398

Legislative bill overview

SB 398 would allow pharmacists to delegate the authority to administer immunizations and vaccines to pharmacy technicians in Texas. This expands the scope of practice for technicians, who currently operate under strict supervision limitations in vaccine administration. The bill aims to streamline vaccine delivery by enabling trained technicians to perform this function independently or with reduced direct oversight.

Why is this important

Vaccine access and administration speed are critical public health issues, especially during disease outbreaks or seasonal campaigns. Delegating this authority could reduce bottlenecks in pharmacies, potentially increasing vaccination rates by making the process faster and reducing wait times. However, this also raises questions about quality control, patient safety oversight, and the adequacy of technician training standards.

Potential points of contention

  • Patient safety standards: Opponents may argue that pharmacists, not technicians, should directly administer vaccines due to their advanced training in recognizing contraindications and managing adverse reactions
  • Technician training requirements: Unclear whether the bill mandates specific additional certification or training beyond current pharmacy technician licensing, creating potential inconsistency in competency levels
  • Liability and oversight: Questions about who bears responsibility if complications arise and whether reduced pharmacist oversight compromises accountability for patient outcomes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.